Ignite Creation Date:
2024-05-06 @ 11:10 AM
Last Modification Date:
2024-10-26 @ 12:41 PM
Study NCT ID:
NCT03447886
Status:
COMPLETED
Last Update Posted:
2021-06-11
First Post:
2018-02-21
Brief Title:
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Understanding Barriers to Initiation and Adherence to Adjuvant Endocrine Therapy in Young Breast Cancer Survivors of Diverse Racial Ethnic and Socio-economic Backgrounds The EMPOWER Study
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The overall goal of this study is to qualitatively explore how behavioral cultural psychosocial and economic barriers and facilitators affect the decision to start and adhere to endocrine therapy ET among young breast cancer survivors of diverse racial ethnic and socio-economic backgrounds with hormone receptor positive HR breast cancer
Detailed Description:
A qualitative study that will use interviews to gain an in depth understanding of factors affecting the decision to start and adhere to endocrine therapy ET among young breast cancer survivors of diverse racial ethnic and socio-economic backgrounds with hormone receptor positive HR breast cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U54CA156732 | NIH | None | httpsreporternihgovquickSearchU54CA156732 |